HBV DNA is undetectable: why do I still need hepatitis B medicine?
Understand why undetectable HBV DNA does not automatically mean treatment can stop, and what to ask your doctor.
Treatment and Follow-up
Introduces monitoring, antiviral treatment concepts, and long-term management education.
Related Articles
When hepatitis B has progressed to cirrhosis: follow-up, complications, and emergency signs
A practical guide for people told they have cirrhosis or advanced fibrosis: antiviral care, cancer surveillance, varices, ascites, medicine safety, nutrition, and emergency signs.
Antiviral treatment and monitoring: what to prepare before each hepatitis B visit
A visit-preparation checklist for chronic hepatitis B care, including HBV DNA, ALT, liver cancer surveillance, medicine adherence, and questions to ask.
Before chemotherapy, immunosuppression, or biologics: do not miss hepatitis B reactivation risk
What HBV reactivation means, which treatments should trigger screening, and what to ask before cancer or immune-suppressing therapy starts.
Chronic hepatitis B and liver cancer screening: when to ask about ultrasound and AFP
A practical guide to who may need liver cancer surveillance, common tests, follow-up intervals, and what to do after abnormal results.
Taking hepatitis B antivirals long term: how to stay on treatment safely and follow up
A practical guide for people taking or starting oral hepatitis B antivirals, covering missed doses, stopping risk, kidney and bone monitoring, pregnancy planning, and follow-up records.
Questions to ask about hepatitis B monitoring
A practical visit checklist for chronic hepatitis B monitoring: what to bring, what to ask, and what should trigger earlier contact.
Related Sources
Hepatitis B Foundation Liver Cancer Screening Recommendations
面向慢性乙肝患者的肝癌筛查说明，强调超声检查、AFP 不能单独用于筛查或诊断，以及慢性乙肝或丙肝患者通常按 6 个月间隔筛查。
Hepatitis B Online Monitoring Persons On and Off HBV Therapy
面向临床学习者的慢性乙肝治疗前后监测说明，涵盖 ALT、HBV DNA、HBeAg/HBsAg 和肝癌筛查等随访项目。
WHO 2024 Chronic Hepatitis B Guidelines
WHO 2024 年慢性乙肝预防、诊断、照护和治疗指南，覆盖检测、治疗、随访和公共卫生策略。
Hepatitis B Foundation Cirrhosis
面向乙肝患者的肝硬化说明，介绍肝硬化、代偿期与失代偿期、并发症、抗病毒治疗和定期随访的重要性。
NIDDK Cirrhosis Symptoms and Causes
NIDDK 关于肝硬化症状和原因的患者说明，涵盖疲乏、瘙痒、黄疸、腹水、出血、意识改变等症状。
ASCO HBV Screening and Management for Patients With Cancer Prior to Therapy
ASCO 关于癌症系统治疗前乙肝筛查和管理的临床意见更新，建议系统抗癌治疗前进行 HBsAg、anti-HBc 和 anti-HBs 检测，并根据风险管理。
AASLD Hepatitis B Guidance
乙肝管理相关临床指导和实践资源。
WHO Hepatitis B Fact Sheet
WHO 关于乙肝传播、预防、疫苗、检测、治疗和全球公共卫生影响的概览。
EASL 2025 Clinical Practice Guidelines on Hepatitis B
EASL 2025 年乙肝临床实践指南，覆盖诊断、治疗目标、治疗适应证、治疗选择、肝癌监测、特殊人群、HBV 再激活预防、移植后照护、预防策略和未来研究问题。
AASLD 2018 Hepatitis B Guidance on Immunosuppressive Therapy
AASLD 2018 乙肝指导中关于免疫抑制或细胞毒性治疗相关 HBV 再激活预防、筛查、预防性抗病毒治疗和监测的建议。
AASLD Practice Guidance on Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma
AASLD 关于肝细胞癌预防、诊断和治疗的实践指导，包含高风险人群监测、超声联合 AFP、约每 6 个月监测和异常结果后进一步诊断评估等建议。
CDC Hepatitis B Surveillance Guidance
Explains HBV laboratory markers, including detectable DNA below the lower limit of quantification.
VA Cirrhosis Patient Guide
美国退伍军人事务部面向患者的肝硬化指南，解释腹水、静脉曲张出血、脑病等并发症和需要急诊处理的警示情况。
Hepatitis B Foundation Patient Resources
面向患者的乙肝诊断、监测、治疗、预防和日常生活资源。
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
中国《慢性乙型肝炎防治指南（2022年版）》的英文发表版本，便于非中文读者检索中国慢乙肝筛查、诊断、预防和治疗建议。
CDC 2023 Hepatitis B Screening and Testing Recommendations
CDC 2023 年乙肝筛查和检测建议，包含成人一次性三项筛查，以及接受或需要细胞毒性、免疫抑制或免疫调节治疗人群的检测建议。
Hepatitis B Online Choosing an Initial HBV Treatment Regimen
面向临床学习者的慢性乙肝初始治疗方案说明，比较恩替卡韦、TDF、TAF 等药物，并讨论肾功能、骨密度、妊娠和合并疾病等用药安全考虑。